Processa Pharmaceuticals (PCSA) Earnings Date, Estimates & Call Transcripts $1.01 -0.04 (-4.23%) (As of 11/15/2024 08:54 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Processa Pharmaceuticals Latest Earnings SummaryUpcoming Q3 Earnings DateApr. 4EstimatedActual EPS (Aug. 13) -$1.01 Missed By -$0.03 Consensus EPS (Aug. 13) -$0.98 Processa Pharmaceuticals posted Q2 2024 earnings on August 13, 2024, reporting an EPS of -$1.01, which missed the consensus estimate of -$0.98 by $0.03. With a trailing EPS of -$3.39, Processa Pharmaceuticals' earnings are expected to grow next year, from ($3.78) to ($2.12) per share. PCSA Upcoming EarningsProcessa Pharmaceuticals' next earnings date is estimated for Friday, April 4, 2025, based off prior year's reporting schedules. Get Processa Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Processa Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPCSA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PCSA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap Profits24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast world of passive crypto income, where you set up a dependable income stream that works for you, whether you're at your computer or living your life.>> Secure Your Spot On The Groundbreaking Workshop Here Processa Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$1.18-$1.18-$1.18Q2 20241-$0.98-$0.98-$0.98Q3 20241-$1.00-$1.00-$1.00Q4 20241-$0.76-$0.76-$0.76FY 20244-$3.92-$3.92-$3.92Q1 20251-$0.66-$0.66-$0.66Q2 20251-$0.55-$0.55-$0.55Q3 20251-$0.47-$0.47-$0.47Q4 20251-$0.48-$0.48-$0.48FY 20254($2.16)($2.16)($2.16) Processa Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 4/4/2025(Estimated)------- 8/13/2024Q2 2024-$0.98-$1.01 -$0.03-$1.01--5/10/2024Q1 2024-$1.18-$1.11+$0.07-$1.11--3/29/2024Q4 2023--$0.24 -$0.24-$0.24--11/13/2023Q3 2023--$1.60 -$1.60-$0.08--8/10/2023Q2 2023--$2.00 -$2.00-$0.10--5/15/2023Q1 2023-$5.60-$3.60+$2.00-$0.18-- Get the Latest News and Ratings for PCSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/30/2023Q4 2022-$5.00-$7.00 -$2.00$0.10-- Processa Pharmaceuticals Earnings - Frequently Asked Questions When is Processa Pharmaceuticals's earnings date? Processa Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, April 4th, 2025 based off last year's report dates. Learn more on PCSA's earnings history. Did Processa Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Processa Pharmaceuticals (NASDAQ:PCSA) missed the analysts' consensus estimate of ($0.98) by $0.03 with a reported earnings per share (EPS) of ($1.01). Learn more on analysts' earnings estimate vs. PCSA's actual earnings. How much profit does Processa Pharmaceuticals generate each year? Processa Pharmaceuticals (NASDAQ:PCSA) has a recorded net income of -$11.12 million. PCSA has generated -$3.39 earnings per share over the last four quarters. What is Processa Pharmaceuticals's EPS forecast for next year? Processa Pharmaceuticals's earnings are expected to grow from ($3.78) per share to ($2.12) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies ONCT Earnings Results SNSE Earnings Results IPA Earnings Results NRXP Earnings Results AWH Earnings Results TSBX Earnings Results AVTX Earnings Results WENA Earnings Results TRIB Earnings Results HCWB Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report 24/7 Automated Profits in Crypto (Ad)What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast world of passive crypto income, where you set up a dependable income stream that works for you, whether you're at your computer or living your life.>> Secure Your Spot On The Groundbreaking Workshop Here This page (NASDAQ:PCSA) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredUS Debt Breaks Records and Threatens Dollar Ahead of ElectionNeed to Rescue Your Retirement in 2024? Help Prevent Inflation from Flushing Your Hard Work Down the DrainPreserve Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Processa Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Processa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
